Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Helle

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependencyS I Helle, S Lundgren, S Geisler, et al.
The Journal of Endocrinology|July 30, 1999
Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smokingJ Geisler, I H Omsjø, S I Helle, et al.
Brain Topography|January 1, 1994
Event-related desynchronization evoked by auditory stimuliC M Krause, H A Lang, M Laine, et al.
British Journal of Cancer|July 20, 2001
Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancerS I Helle, J Geisler, G B Anker, et al.
International Journal of Cancer|August 22, 1996
Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patientsS I Helle, J M Holly, M Tally, et al.
Cancer|March 26, 1999
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinomaE P Diamandis, S I Helle, H Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancerV J Frost, S I Helle, P E Lønning, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.
Frontiers in Oncology|April 17, 2023
Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort studyCamilla Kjellstadli, Rachel B Forster, Tor Å Myklebust, et al.
Clinical Endocrinology|December 1, 1996
Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over studyS I Helle, I H Omsjø, S C Hughes, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependencyS I Helle, S Lundgren, S Geisler, et al.
The Journal of Endocrinology|July 30, 1999
Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smokingJ Geisler, I H Omsjø, S I Helle, et al.
Brain Topography|January 1, 1994
Event-related desynchronization evoked by auditory stimuliC M Krause, H A Lang, M Laine, et al.
British Journal of Cancer|July 20, 2001
Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancerS I Helle, J Geisler, G B Anker, et al.
International Journal of Cancer|August 22, 1996
Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patientsS I Helle, J M Holly, M Tally, et al.
Cancer|March 26, 1999
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinomaE P Diamandis, S I Helle, H Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancerV J Frost, S I Helle, P E Lønning, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.
Frontiers in Oncology|April 17, 2023
Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort studyCamilla Kjellstadli, Rachel B Forster, Tor Å Myklebust, et al.
Clinical Endocrinology|December 1, 1996
Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over studyS I Helle, I H Omsjø, S C Hughes, et al.
Pageof 4